Skip to main content

Precision medicine

04:00 pm | April 22, 2026
From 19 to 21 May 2026, health leaders and professionals from Europe and beyond will gather at Bella Centre in Copenhagen, Denmark, to learn, connect and innovate. Get all the coverage from the event on this page.
By Andrea Fox | 11:36 am | April 22, 2026
To bring novel precision evidence to existing workflows, the company said its growing medical library is accessible through more artificial intelligence-driven clinical technologies from Meta, Heidi Health, Humata and others.
By Adam Ang | 09:06 pm | March 23, 2026
A $4.7 million collaboration led by the National Cancer Centre Singapore will develop a clinical-grade test using AI and advanced genomic sequencing for more precise cancer profiling.
By Adam Ang | 08:42 pm | March 23, 2026
Also, Flinders University has launched a new website supporting the self-management of stroke.
By Adam Ang | 12:51 am | March 11, 2026
A doctor-tech leader from India argues that genomic data infrastructure, resistance forecasting and sovereign AI discovery tools will be critical to future regional pandemic response.
By HIMSS TV | 08:05 pm | March 09, 2026
Care delivery might become more personalized, "tailored and swift" during a Taylor Swift administration, says General Catalyst's Stephen Klasko, keynote speaker at the HIMSS26 Smart Health Transformation Forum.
By HIMSS TV | 09:28 am | March 06, 2026
Mount Sinai Health System, ARC Innovation Center and Nvidia are working together to apply AI to vast datasets that could unlock genomic insights and help researchers better understand how patients could respond to therapies.
By Proscia | 05:16 pm | February 23, 2026
As pathology moves into the digital era, clinical laboratories, academic medical centers and health systems are navigating unprecedented volumes of high-resolution whole-slide image data, siloed archives and the growing imperative to deploy AI-driven workflows.
By HIMSS TV | 09:25 am | February 12, 2026
CustoMED uses 3D printing to create patient-specific surgical instruments designed to precisely match each patient's anatomy. Dr. Amit Zabtani, the company’s cofounder and chief medical officer and an orthopedic surgeon at UCLA, explains.
By Jessica Hagen | 10:09 am | February 06, 2026
Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular imaging and targeted therapy is personalizing cancer care.